BR0104169A - Sistema de anel condensado contendo indol como antagonistas aza-antracênicos seletivos do receptor muscarìnico m4 - Google Patents

Sistema de anel condensado contendo indol como antagonistas aza-antracênicos seletivos do receptor muscarìnico m4

Info

Publication number
BR0104169A
BR0104169A BR0104169-0A BR0104169A BR0104169A BR 0104169 A BR0104169 A BR 0104169A BR 0104169 A BR0104169 A BR 0104169A BR 0104169 A BR0104169 A BR 0104169A
Authority
BR
Brazil
Prior art keywords
substituted
hydrogen
lower alkyl
aza
ring system
Prior art date
Application number
BR0104169-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Corinne Elizab Augelli-Szafran
Thomas M Boehme
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0104169A publication Critical patent/BR0104169A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR0104169-0A 2000-09-22 2001-09-20 Sistema de anel condensado contendo indol como antagonistas aza-antracênicos seletivos do receptor muscarìnico m4 BR0104169A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23482600P 2000-09-22 2000-09-22

Publications (1)

Publication Number Publication Date
BR0104169A true BR0104169A (pt) 2002-07-09

Family

ID=22882987

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0104169-0A BR0104169A (pt) 2000-09-22 2001-09-20 Sistema de anel condensado contendo indol como antagonistas aza-antracênicos seletivos do receptor muscarìnico m4

Country Status (6)

Country Link
US (1) US6500837B2 (cg-RX-API-DMAC7.html)
EP (1) EP1191027A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002114786A (cg-RX-API-DMAC7.html)
BR (1) BR0104169A (cg-RX-API-DMAC7.html)
CA (1) CA2357306A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01009550A (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072549A1 (en) * 2001-03-12 2002-09-19 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
MX2021011588A (es) * 2019-03-25 2021-12-15 Cold Spring Harbor Laboratory Antagonistas del receptor muscarinico de acetilcolina subtipo 4 en el tratamiento de la anemia.

Also Published As

Publication number Publication date
US6500837B2 (en) 2002-12-31
EP1191027A1 (en) 2002-03-27
CA2357306A1 (en) 2002-03-22
JP2002114786A (ja) 2002-04-16
US20020068752A1 (en) 2002-06-06
MXPA01009550A (es) 2002-04-12

Similar Documents

Publication Publication Date Title
WO2001066534A3 (en) Cyclic and bicyclic diamino histamine-3 receptor antagonists
WO2003029199A1 (en) Benzene derivatives, process for preparing the same and use thereof
AU2002212226A1 (en) Use of indole derivatives for treating illnesses of the central nervous system
MA31521B1 (fr) Dérivés de 2,3-dihydrobenzo[1,4] dioxin-2-ylméthyle utilisés en tant qu'antagonistes des alpha2c pour traiter des maladies des systèmes nerveux périphérique et central
WO2002012442A3 (en) Heterocyclic compounds as ligands of the gabaa receptor
DE60001983T2 (de) Bicyclische und tricyclische heteroaromatische verbindungen
BR0317600A (pt) ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
MXPA06014721A (es) Derivados de alquinilo como moduladores de los receptores de glutamato metabotropico.
NO20062139L (no) Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
BRPI0413233A (pt) novos compostos
BR0309463A (pt) Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade
AU3060197A (en) Aryl substituted cyclic amines as selective dopamine d3 ligands
CA2359008A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
BR0213464A (pt) Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide
IL191763A0 (en) Pyrrolo [2,3-b]pyridine derivatives as h3 receptor modulators
BR0311593A (pt) Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc
WO2005080352A3 (en) Quinazoline derivatives and therapeutic use thereof
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
BRPI0413820A (pt) derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
TR200001452T2 (tr) Bifenilamidin türevleri.
DK1194415T3 (da) Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling
WO2002011732A8 (en) Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
AU1028601A (en) Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity
WO2008052088A8 (en) Chromane derivatives, synthesis thereof, and intermediates thereto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTEAO DESPACHO 8.6 DA RPI 2014 DE 11/08/2009.